-
1Academic Journal
المؤلفون: P. Chernyavsky V., M. Mazanov Kh., I. Argir A., N. Bikbova M., S. Kambarov Yu., M. Sagirov A., A. Dublev V., A. Timerbaev V., N. Kharitonova I., П. Чернявский В., М. Мазанов Х., И. Аргир А., Н. Бикбова М., С. Камбаров Ю., М. Сагиров А., А. Дублев В., А. Тимербаев В., Н. Харитонова И.
المساهمون: The study had no sponsorship, Исследование не имеет спонсорской поддержки
المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 1 (2022); 50-58 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 1 (2022); 50-58 ; 2541-8017 ; 2223-9022
مصطلحات موضوعية: surgical reconstruction of the left ventricle, coronary artery disease, heart failure, myocardial infarction, coronary bypass grafting, хирургическая реконструкция левого желудочка, ишемическая болезнь сердца, сердечная недостаточность, инфаркт миокарда, коронарное шунтирование
وصف الملف: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/1339/1086; Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998;97(3):282–289. PMID: 9462531 https://doi.org/10.1161/01.cir.97.3.282 15; Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87(3):755–763. PMID: 8443896 https://doi.org/10.1161/01.cir.87.3.755; Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443. PMID: 11794191 https://doi.org/10.1056/NEJMoa012175; Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40(6):633–644. PMID: 449273; Sallin EA. Fiber orientation and ejection fraction in the human left ventricle. Biophys J. 1969;9(7):954–964. PMID: 5791550 https://doi.org/10.1016/S0006-3495(69)86429-5; White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76(1):44–51. PMID: 3594774 https://doi.org/10.1161/01.cir.76.1.44; Buckberg GD. Defining the relationship between akinesia and dyskinesia and the cause of left ventricular failure after anterior infarction and reversal of remodeling to restoration. J Thorac Cardiovasc Surg. 1998;116(1):47–49. PMID: 9671896 https://doi.org/10.1016/s0022-5223(98)70241-7; Di Donato M, Sabatier M, Dor V, Gensini GF, Toso A, Maioli M, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg. 2001;121(1):91–96. PMID: 11135164 https://doi.org/ 910.1067/mtc.2001.111379; Jatene AD. Left ventricular aneurysmectomy. Resection or reconstruction. J Thorac Cardiovasc Surg. 1985;89(3):321–331. PMID: 3974267; Dor V. Reconstructive left ventricular surgery for post-ischemic akinetic dilatation. Semin Thorac Cardiovasc Surg. 1997;9(2):139–145. PMID: 9253076; Di Donato M, Sabatier M, Dor V, Toso A, Maioli M, Fantini F. Akinetic versus dyskinetic postinfarction scar: relation to surgical outcome in patients undergoing endoventricular circular patch plasty repair. J Am Coll Cardiol. 1997;29(7):1569–1575. PMID: 9180121 https://doi.org/10.1016/s0735-1097(97)00092-2; Kennedy JW, Baxley WA, Figley MM, Dodge HT, Blackmon JR. Quantitative angiocardiography. I. The normal left ventricle in man. Circulation. 1966;34(2):272–278. PMID: 5969358 https://doi.org/10.1161/01.cir.34.2.272; Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coro nary Arteries (GUSTO)-I Angiographic Investigators. Circulation. 1997;96(1):116–121. PMID: 9236425 https://doi.org/10.1161/01.cir.96.1.116; Ingels NB Jr. Myocardial fiber architecture and left ventricular function. Technol Health Care. 1997;5(1–2):45–52. PMID: 9134618; Bogaert J, Bosmans H, Maes A, Suetens P, Marchal G, Rademakers FE. Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study. J Am Coll Cardiol. 2000;35(6):1525–1534. PMID: 10807456 https://doi.org/10.1016/s0735-1097(00)00601-x; Di Donato M, Sabatier M, Toso A, Barletta G, Baroni M, Dor V, et al. Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm: effects of aneurysmectomy. Eur Heart J. 1995;16(9):1285–92. PMID: 8582393 https://doi.org/10.1093/oxfordjournals.eurheartj.a061087; Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785–795. PMID: 6352078 https://doi.org/10.1161/01.cir.68.4.785; Elefteriades J, Edwards R. Coronary bypass in left heart failure. Semin Thorac Cardiovasc Surg. 2002;14(2):125–132. PMID: 11988950 https://doi.org/10.1053/stcs.2002.32321; Shah PJ, Hare DL, Raman JS, Gordon I, Chan RK, Horowitz JD, et al. Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study. J Thorac Cardiovasc Surg. 2003;126(5):1320–1327. PMID: 14666002 https://doi.org/10.1016/s0022-5223(03)00809-2; Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998;66(5):1632–1639. PMID: 9875763 https://doi.org/10.1016/s0003-4975(98)00773-5; Louie HW, Laks H, Milgalter E, Drinkwater DC Jr, Hamilton MA, Brunken RC, et al. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation. 1991;84(5 Suppl):III290–5. PMID: 1934422; Yamaguchi A, Ino T, Adachi H, Murata S, Kamio H, Okada M, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998;65(2):434–438. PMID: 9485241 https://doi.org/10.1016/s0003-4975(97)01155-7; Luciani GB, Montalbano G, Casali G, Mazzucco A. Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2000;120(3):478–489. PMID: 10962408 https://doi.org/10.1067/mtc.2000.108692; Stanley AW Jr., Athanasuleas CL, Buckberg GD. Left ventricular remodeling and functional mitral regurgitation: mechanisms and therapy. Semin Thorac Cardiovasc Surg. 2001;13(4):486–495. PMID: 11807745 https://doi.org/10.1053/stcs.2001.30135; Enriquez-Sarano M, Schaff HV, Frye RL. Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation. 2003;108(3):253–256. PMID: 12876134 https://doi.org/10.1161/01.CIR.0000083831.17708.25; Dahlberg PS, Orszulak TA, Mullany CJ, Daly RC, Enriquez-Sarano M, Schaff HV. Late outcome of mitral valve surgery for patients with coronary artery disease. Ann Thorac Surg. 2003;76(5):1539–1548. PMID: 14602283 https://doi.org/10.1016/s0003-4975(03)01071-3; Di Donato M, Toso A, Maioli M, Sabatier M, Stanley AW Jr, Dor V. Intermediate survival and predictors of death after surgical ventricular restoration. Semin Thorac Cardiovasc Surg. 2001;13(4):468–475. PMID: 11807742 https://doi.org/10.1053/stcs.2001.29972; Keck BM, Bennett LE, Rosendale J, Daily OP, Novick RJ, Hosenpud JD. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl. 1999;35–49. PMID: 11038624; https://www.jnmp.ru/jour/article/view/1339
-
2Academic Journal
المؤلفون: M. Mazanov K., P. Chernyavsky V., M. Sagirov A., N. Bikbova M., N. Kharitonova I., D. Chernyshev V., A. Timerbayev V., S. Kambarov Y., М. Мазанов Х., П. Чернявский В., М. Сагиров А., Н. Бикбова М., Н. Харитонова И., Д. Чернышев В., А. Тимербаев В., С. Камбаров Ю.
المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 9, № 3 (2020); 377-382 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 9, № 3 (2020); 377-382 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2020-9-3
مصطلحات موضوعية: left ventricular dysfunction, coronary artery bypass grafting, левожелудочковая дисфункция, коронарное шунтирование
وصف الملف: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/946/783; https://www.jnmp.ru/jour/article/view/946/876; Trachiotis GD, Weintraub WS, Johnston TS, Jones EL, Guyton RA, Craver JM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg. 1998;66(5):1632–1639. PMID: 9875763 https://doi.org/10.1016/s0003-4975(98)00773-5; Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785–795. PMID: 6352078 https://doi.org/10.1161/01.cir.68.4.785; Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrell FE, Jr Lee KL, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation. 1988;78(3Pt 2):1151–1157. PMID: 3261652; Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57(6):1402–1407. PMID: 8010780 https://doi.org/10.1016/0003-4975(94)90091-4; Hillis GS, Zehr KJ, Williams AW, Schaff HV, Orzulak TA, Daly RC, et al. Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: renal function and mortality after 3.8 years. Circulation. 2006;114(1Suppl):I414–441. PMID: 16820610 https://doi.org/10.1161/circulationaha.105.000661; Shapira OM, Hunter CT, Anter E, Bao Y, DeAndrade K, Lazar HL, et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction early and mid-term outcomes. J Card Surg. 2006;21(3):225–232. PMID: 16684046 https://doi.org/10.1111/j.1540-8191.2006.00221.x; Topkara V, Cheema FH, Kesavaramanujam S, Mercando ML,Cheema AF, Namerow PB, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112(9 Suppl):I344–350. PMID: 16159844 https://doi.org/10.1161/CIRCULATIONAHA.104.526277; Carr JA, Haithcock BE, Paone G, Bernabei AF, Silverman NA. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg. 2002;74(5):1531–1536. PMID: 12440604 https://doi.org/10.1016/s0003-4975(02)03944-9; O’Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, et al. Comparison of coronary artery bypass grafting versus medical therapy on long term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90(2):101–107. PMID: 12106836 https://doi.org/10.1016/s0002-9149(02)02429-3; Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616. PMID: 21463150 https://doi.org/10.1056/nejmoa1100356; Elefteriades JA, Tolis GJr, Levi E, Mills LK, Zaret BL. Coronaryartery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22(5):1411–1417. PMID: 8227799 https://doi.org/10.1016/07351097(93)90551-b; Haxhibeqiri-Karabdic I, Hasanovic A, Kabil E, Straus S. Improvement of ejection fraction after coronary artery bypass grafting surgery in patients with impaired left ventricular function. Med Arch. 2014;68(5):332–334. PMID: 25568566 https://doi.org/10.5455/medarh.2014.68.332-334; Lozonschi L, Kohmoto T, Osaki S, De Oliveira NC, Dhingra R, Akhter SA, et al. Coronary bypass in left ventricular dysfunction and differential cardiac recovery. Asian Cardiovasc Thorac Ann. 2017;25(9):586–593. PMID: 29153000 https://doi.org/10.1177/0218492317744472; Wang J, Xiao F, Ren J, Li Y, Zhang ML. Risk factors for mortality after coronary artery bypass grafting in patients with low left ventricular ejection fraction. Chin Med J (Engl). 2007;120(4):317–322. PMID: 17374284 https://doi.org/10.1097/00029330-200702020-00012; https://www.jnmp.ru/jour/article/view/946
-
3Academic Journal
المؤلفون: I. Brand B., M. Mazanov K., A. Timerbayev V., M. Sagirov A., N. Kharitonova I., M. Chymakov V., Я. Бранд Б., М. Мазанов Х., А. Тимербаев В., М. Сагиров А., Н. Харитонова И., М. Чумаков В.
المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 6, № 3 (2017); 251-256 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 6, № 3 (2017); 251-256 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2017-6-3
مصطلحات موضوعية: long-term results, coronary artery bypass grafting, acute coronary syndrome, отдаленные результаты, коронарное шунтирование, острый коронарный синдром
وصف الملف: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/390/458; Григорян В.К., Хубулава Г.Г., Кравчук В.Н., Пелешок А.С. Оценка результатов коронарного шунтирования у пациентов с острыми формами ИБС в условиях искусственного кровообращения. Бюллетень НЦССХ им. А.Н.Бакулева РАМН «Сердечно-сосудистые заболевания». 2011; 12(6): 55.; Бранд Я.Б., Долгов И.М., Мазанов М.Х., и др. Результаты операций реваскуляризации миокарда у больных средней постинфарктной стенокардией (десятилетний опыт). В кн.: Материалы 1-й съезда врачей неотложной медицины [г. Москва, 5–6 апреля 2012г.]. М.: НИИ СП им. Н.В. Склифосовского, 2012. Труды ин-та, Т. 225: 14.; Caine N., Harrison S.C., Sharples L.D., et al. Prospective study of quality of life before and after coronary artery bypass grafting. Br. Med. J. 1991; 302(6775): 511–516. PMID: 2012849 PMCID: PMC1669629.; Hlatky M.A., Boothroyd D.B., Melsop K.A., et al. Medical costs and quality of life 10 to 12 years after randomisation to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation. 2004; 110(14): 1960–1966. PMID: 15451795.; Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 2013; 368(21): 2004–2013. PMID: 23697515 doi:10.1056/NEJMra1216063.; McManus D.D., Gore J., Yarzebski J., et al. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am. J. Med. 2011; 124: 40–47. PMID: 21187184 doi:10.1016/ j.amjmed.2010.07.023.; Terkelsen C.J., Lassen J.F., Norgaard B.L., et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur. Heart J. 2005; 26: 18–26. PMID: 15615795 doi:10.1093/eurheartj/ehi002.; Ben-Gal Y., Moses J.W., Mehran R., et al. Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. JACC Cardiovasc. Interv. 2010; 3(10): 1059–1067. PMID: 20965465 doi:10.1016/j.jcin.2010.06.017.; Бранд Я.Б., Мазанов М.Х., Чумаков М.В., и др. Эффективность применения левосимендана у больных с ОКС с исходно сниженной систолической функцией левого желудочка при операции реваскуляризации миокарда. В кн.: Актуальные направления современной кардиоторакальной хирургии: прогр., сб. тез. докл. III междунар. конгр., (г. Санкт-Петербург, 26–30 июня 2013г.). СПб., 2013: 57–58.; Бранд Я.Б., Мазанов М.Х., Чумаков М.В., и др. Оценка эффективности Левосимендана у больных с острым коронарным синдромом при операции прямой реваскуляризации миокарда. Бюллетень НЦССХ им. А.Н. Бакулева «Сердечно-сосудистая хирургия». 2013; 14 (3), Прил.: Тезисы докл. XVII ежегод. сессии НЦССХ им. А.Н. Бакулева РАМН с Всерос. конф. молодых ученых, (г. Москва, 19–21 мая 2013 г.): 39.; Поплавский И.В., Чернышев Д.В., Бранд Я.Б., и др. Сравнение ранних результатов выполнения экстренной и экстренно-отсроченной прямой реваскуляризации миокарда у пациентов с острым коронарным синдромом. Грудная и сердечно — сосудистая хирургия. 2010; (6): 17–22.; Бранд Я.Б., Тимербаев В.Х., Долгов И.М., и др. Опыт использования внутриаортальной баллонной контрпульсации при выполнении прямой реваскуляризации миокарда у пациентов с острым коронарным синдромом. Кардиология и сердечно-сосудистая хирургия. 2011; (3): 22–26.; Бранд Я.Б., Долгов И.М., Мазанов М.Х., и др. Результаты выполнения пластики коронарных артерий после открытой и комбинированной эндартерэктомии у пациентов с тяжелыми формами ишемической болезни сердца. Кардиология и сердечно-сосудистая хирургия. 2010; (2): 12–15.; https://www.jnmp.ru/jour/article/view/390
-
4Academic Journal
المؤلفون: K. Alidzhanova G., O. Rzhevskaya N., M. Sagirov A., G. Gazaryan A., Х. Алиджанова Г., О. Ржевская Н., М. Сагиров А., Г. Газарян А.
المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 6, № 2 (2017); 132-139 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 6, № 2 (2017); 132-139 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2017-6-2
مصطلحات موضوعية: chronic kidney disease, glomerular filtration rate, coronary atherosclerosis, acute coronary syndrome, myocardial revascularization, хроническая болезнь почек, скорость клубочковой фильтрации, атеросклероз коронарных артерий, острый коронарный синдром, реваскуляризация миокарда
وصف الملف: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/361/428; Моисеев B.C., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио- и нефропротекции. Российский кардиологический журнал. 2014; 8(112): 7–37.; Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007; 29(23): 2630–2633. DOI:10.1001/jama.297.23.2630.; Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15(5): 1307–1315. PMID: 15100371.; Briasoulis A., Bakris G.L. Chronic kidney disease as a coronary artery disease risk equivalent. Curr. Cardiol. Rep.2013; 15(3): 340. DOI:10.1007/s11886-012-0340-4.; Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann. Intern. Med. 2002; 137(7): 563–570. DOI:10.7326/0003-4819-137-7-200210010-00007.; Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am. J. Kidney Dis. 1998; 32(5): 853–906. DOI:10.1016/S0272-6386(98)70145-3.; Herzog C.A., Li S., Weinhandl E.D., et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005; 68(2): 818–825. DOI:10.1111/j.1523-1755.2005.00462.x.; Franczyk-Skóra B., Gluba A., Olszewski R., et al. Heart function disturbances in chronic kidney disease – echocardiographic indices. Arch. Med. Sci. 2014; 10(6): 1109–1116. DOI:10.5114/aoms.2014.47822.; Kilickesmez K.O., Abaci O., Okcun B., et al. Chronic kidney disease as a predictor of coronary lesion morphology. Angiology. 2010; 61(4): 344–349. DOI:10.1177/0003319709351875.; Sabe M.A., Claggett B., Burdmann E.A., et al. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J. Am. Heart Assoc. 2016; 5(4): e002850. DOI:10.1161/JAHA.115.002850.; Balla S., Nusair M.B., Alpert M.A. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin. Pharmacol. 2013; 13(2): 192–199. DOI:10.1016/j.coph.2012.12.001.; Olechnowicz-Tietz S., Gluba A., Paradowska A., et al. The risk of atherosclerosis in patients with chronic kidney disease. Int. Urol. Nephrol. 2013; 45(6): 1605–1612. DOI:10.1007/s11255-013-0407-1.; Schlieper G., Schurgers L., Brandenburg V., et al. Vascular calcification in chronic kidney disease: an update. Nephrol. Dial. Transplant. 2016; 31(1): 31–39. DOI:10.1093/ndt/gfv111.; Gupta J., Mitra N., Kanetsky P.A., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin. J. Am. Soc. Nephrol. 2012; 7(12): 1938–1946. DOI:10.2215/CJN.03500412.; Gupta J., Dominic E.A., Fink J.C., et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC Study. PLoS ONE. 2015; 10(4): e0124772. DOI:10.1371/journal.pone.0124772.; Kato K., Yonetsu T., Jia H., et al. Non–culprit coronary plaque characteristics of chronic kidney disease. Circ. Cardiovasc. Imaging. 2013; 6(3): 448–456. DOI:10.1161/CIRCIMAGING.112.000165.; Madhavan M.V., Tarigopula M., Mintz G.S., et al. Coronary artery calcification: pathogenesis and prognostic implications. J. Am. Coll. Cardiol. 2014; 63(17): 1703–1714. DOI:10.1016/j.jacc.2014.01.017.; Goodman W.G., London G., Amann K., et al. Vascular calcification in chronic kidney disease. Am. J. Kidney Dis. 2004; 43(3): 572–579. PMID: 14981617.; Kiu Weber C.I., Duchateau-Nguyen G., Solier C., et al. Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clin. Kidney J. 2014; 7(2): 167–173. DOI:10.1093/ckj/sfu017.; Kawai H., Sarai M., Motoyama S., et al. Coronary plaque characteristics in patients with mild chronic kidney disease. Analysis by 320-row area detector computed tomography. Circ. J. 2012; 76(6): 1436–1441. PMID: 22453001.; Ohtake T., Kobayashi S., Moriya H., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J. Am. Soc. Nephrol. 2005; 16(4): 1141–1148. DOI:10.1681/ASN.2004090765.; Nakano T., Ninomiya T., Sumiyoshi S., et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am. J. Kidney Dis. 2010; 55(1): 21–30. DOI:10.1053/j.ajkd.2009.06.034.; Charytan D.M., Shelbert H.R., Di Carli M.F. Coronary microvascular function in early chronic kidney disease. Circ. Cardiovasc. Imaging. 2010; 3(6): 663–671. DOI:10.1161/CIRCIMAGING.110.957761.; Matsushita K., Coresh J., Sang Y., et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015; 3(7): 514–525. DOI:10.1016/S2213-8587(15)00040-6.; Tonelli M., Muntner P., Lloyd A., et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844): 807–814. DOI:10.1016/S0140-6736(12)60572-8.; McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med. 2007; 67(11): 1122–1129. DOI:10.1001/archinte.167.11.1122.; Hui X., Matsushita K., Sang Y., et al. CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race. Am. J. Kidney Dis. 2013; 62(4): 691–702. DOI:10.1053/j.ajkd.2013.04.010.; Masoudi F.A., Plomondon M.E., Magid D.J., et al. Renal insufficiency and mortality from acute coronary syndromes. Am. Heart J. 2004; 147(4): 623–629. DOI:10.1016/j.ahj.2003.12.010.; Smith G.L., Masoudi F.A., Shlipak M.G., et al. Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction. J. Am. Soc. Nephrol. 2008; 19(1): 141–150. DOI:10.1681/ASN.2007050554.; Rozenbaum Z., Leader A., Neuman Y., et al. Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome. Am. J. Med. 2016; 129(2): 187–194. DOI:10.1016/j.amjmed.2015.08.017.; Ozaki T., Yamada T., Morita T., et al. The ratio of contrast media volume to the estimated glomerular filtration rate and syntax score predict 3-year poor outcome in patients with acute coronary syndrome and chronic kidney disease undergoing emergency coronary procedure. J. Am. Coll. Cardiol. 2016; 67(13 Suppl): S70.; Pun P.H., Al-Khatib S.M., Han J.Y., et al. Implantable cardioverterdefibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am. J. Kidney Dis. 2014; 64(1): 32–39. DOI:10.1053/j.ajkd.2013.12.009.; Inrig J.K., Patel U.D., Briley L.P., et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol. Dial. Transplant. 2008; 23(3): 934–940. DOI:10.1093/ndt/gfm689.; Fox C.S., Muntner P., Chen A.Y., et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry. Circulation. 2010; 121(3): 357–365. DOI:10.1161/CIRCULATIONAHA.109.865352.; Lee S.H., Kim YJ, Kim W., et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ. J. 2008; 72(9): 1410–1418. PMID: 18724014.; Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002; 106(8): 974–980. PMID: 12186803.; Cardarelli F., Bellasi A., Ou F.S., et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103(6): 766–771. DOI:10.1016/j.amjcard.2008.11.033.; Saad M., Karam B., Faddoul G., et al. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int. J. Nephrol. Renovasc. Dis. 2016; 9: 5–10. DOI:10.2147/IJNRD.S91567.; Seifert M.E., de Las Fuentes L., Ginsberg C., et al. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am. J. Nephrol. 2014; 39(5): 392–399. DOI:10.1159/000362251.; Collins A.J., Foley R., Herzog C., et al. Excerpts from the United States Renal Data System 2007 annual data report. Am. J. Kidney Dis. 2008; 51(1 Suppl 1): S1–S320. DOI:10.1053/j.ajkd.2007.11.001.; Sittichanbuncha Y., Sricharoen P., Tangkulpanich P., Sawanyawisuth K. The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients. Ther. Clin. Risk. Manag. 2015; 11: 1143–1147. DOI:10.2147/TCRM.S85671.; Twerenbold R., Wildi K., Jaeger C., et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015; 131(23): 2041–2050. DOI:10.1161/CIRCULATIONAHA.114.014245.; Bangalore S., Guo Y., Samadashvili Z., et al. Revascularization in Patients with Multivessel Coronary Artery Disease and Chronic Kidney Disease Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery. J. Am. Coll. Cardiol. 2015; 66(11): 1209–1220. DOI:10.1016/j.jacc.2015.06.1334.; Szummer K., Lundman P., Jacobson S.H., et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009; 120(10): 851–858. DOI:10.1161/CIRCULATIONAHA.108.838169.; Baber U., Mehran R. Coronary Artery Revascularization in Chronic Kidney Disease Time for a Randomized Trial. Circ. Cardiovasc. Interv. 2015; 8(1): e002140. DOI:10.1161/CIRCINTERVENTIONS.114.002140.; James M.T., Pannu N. Early-invasive strategies for the management of coronary heart disease in chronic kidney disease: is acute kidney injury a consideration? Curr. Opin. Nephrol. Hypert. 2014; 23(3): 283–290. DOI:10.1097/01.mnh.0000444819.03121.4b.; Shroff G.R., Solid C.A., Herzog C.A. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013; 127(18): 1861–1869. DOI:10.1161/CIRCULATIONAHA.112.001264.; Ertelt K., Généreux P., Mintz G.S., et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am. J. Cardiol. 2013; 112(11): 1730–1737. DOI:10.1016/j.amjcard.2013.07.038.; Castagna M.T., Mintz G.S., Ohlmann P., et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005; 111(9): 1148–1152. DOI:10.1161/01.CIR.0000157160.69812.55.; Roberts J.K., McCullough P.A. The management of acute coronary syndromes in patients with chronic kidney disease. Adv. Chronic. Kidney Dis. 2014; 21(6): 472–479. DOI:10.1053/j.ackd.2014.08.005.; Rhee J.W., Wiviott S.D., Scirica B.M., et al. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin. Cardiol. 2014; 37(6): 350–356. DOI:10.1002/clc.22253.; Palmer S.C., Di Micco L., Razavian M. et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013; 2: CD008834. DOI:10.1002/14651858.CD008834.pub2.; Nauta S.T., van Domburg R.T., Nuis R.J., et al. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int. 2013; 84(2): 353–358. DOI:10.1038/ki.2013.71.; Kurtul A., Murat S.N., Yarlioglues M., et al. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. Angiology. 2015; 66(7): 644–651. DOI:10.1177/0003319714546738.; Tsai T.T., Messenger J.C., Brennan M.J., et al. Safety and efficacy of drugeluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J. Am. Coll. Cardiol. 2011; 58(18): 1859–1869. DOI:10.1016/j.jacc.2011.06.056.; Chan W., Ivanov J., Ko D., et al. Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario. Circ. Cardiovasc. Interv. 2015; 8(1): e001973. DOI:10.1161/CIRCINTERVENTIONS.114.001973.; Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2015; 10(9): 1024–1094. DOI:10.4244/EIJY14M09_01.; Bangalore S., Vlachos H.A., Selzer F., et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc. Interv. 2011; 77(1): 22–28. DOI:10.1002/ccd.22613.; Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA. 2005; 293(17): 2126–2130. DOI:10.1001/jama.293.17.2126.; https://www.jnmp.ru/jour/article/view/361
-
5Academic Journal
المؤلفون: G. Gazaryan A., Y. Taraseyeva V., M. Sagirov A., L. Tyurina G., M. Zhizhina N., E. Nefedova A., Kh. Alidzhanova G., А. Газарян, Я. Тарасеева В., М. Сагиров А., Л. Тюрина Г., М. Жижина Н., Г. Нефедова А., Х. Алиджанова Г.
المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; № 4 (2016); 56-60 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; № 4 (2016); 56-60 ; 2541-8017 ; 2223-9022 ; undefined
مصطلحات موضوعية: recurrent myocardial infarction, early and delayed roentgen-endovascular coronary interventions, surgical revascularization after myocardial scarring, hospital and long-term mortality, повторный инфаркт миокарда, ранние и отсроченные рентгенэндоваскулярные коронарные вмешательства, хирургическая реваскуляризация после рубцевания миокарда, госпитальная и отдаленная летальность
وصف الملف: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/323/392; Мясников А.Л. О некрозах миокарда // Кардиология. – 1962. – № 1. – C. 3–8.; Попов В.Г. Повторные инфаркты миокарда. - М.: Медицина, 1971. – 200 с.; Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction // Eur. Heart J. – 2007. – Vol. 28, N. 20. – P. 2525–2538.; Mendis S., Thygesen K., Kuulasmaa K., et al. World Health Organization definition of myocardial infarction: 2008–09 revision // Int. J. Epidemiol. – 2011. – Vol. 40, N. 1. – P. 139–146.; Thygesen K., Alpert J.S., Jaffe A.S., et al. Third Universal Definition of Myocardial Infarction // J. Am. Coll. Cardiol. – 2012. – Vol. 60, N. 16. – P. 1581–1598.; Ahumada M, Cabades A., Valencia J., et al. Reinfarction as a complication of acute myocardial infarction. PRIMVAC Registry data // Rev. Esp. Cardiol. – 2005. – Vol. 58, N. 1. – P. 13–19.; Gibson C.M., Karha .J, Murphy S.A., et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials // J. Am. Coll. Cardiol. – 2003. – Vol. 42, N. 1. – P. 7–16.; Williams D.O., Braunwald E., Knatterud G., et al. One year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial // Circulation. – 1992. – Vol. 85, N. 2. – P. 533–542.; Хубутия М.Ш., Газарян Г.А., Захаров И.В. Реперфузионная терапия в остром периоде инфаркта миокарда. – М.: ГЭОТАР-Медиа, 2010. – 168 с.; Тарасеева Я.В., Газарян Л.Г., Макаова Ф.М. и др. Ближайшие и отдаленные результаты реперфузионной стратегии лечения повторного инфаркта миокарда // Инновации и прогресс в кардиологии: материалы Рос. нац. конгр. кардиологов, г. Казань, 24–26 сент. 2014 г. – Казань, 2014. – С. 453–454. – Сообщ. 0590.; Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: a convenient,bedside,clinical score for risk assessment at presentation. An intravenous nPA for treatment of infracting myocardium early II trial substudy // Circulation. – 2000. – Vol. 102, N. 17. – P. 2031–2037.; Fiol M., Cygankiewich I., Guindo J., et al. Evolving myocardial infarction with ST elevation: ups and downs of ST in different leads identifies the culprit artery and location of the occlusion // Ann. Noninvasive Electrocardial. – 2004. – Vol. 9, N. 2. – P. 180–186.; Krucoff M.W, Croll M.A., Pope J.E., et al. Continuous 12-lead ST segment recovery analysis in the TАMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion // Circulation. – 1993. – Vol. 88, N. 2. – P. 437–446.; https://www.jnmp.ru/jour/article/view/323; undefined
-
6
المؤلفون: A Iu, Romakov, V M, Desiatnichenko, A M, Sagirov, Iu S, Sobol', E V, Kokurina
المصدر: Klinicheskaia meditsina. 62(1)
مصطلحات موضوعية: Male, Clinical Trials as Topic, Physical Exertion, Drug Resistance, Humans, Middle Aged, Propranolol, Angina Pectoris
-
7
المؤلفون: N A, Mazur, A B, Sumarokov, A M, Sagirov
المصدر: Kardiologiia. 25(9)
مصطلحات موضوعية: Adult, Nitroglycerin, Nifedipine, Verapamil, Heart Rate, Humans, Blood Pressure, Coronary Disease, Drug Therapy, Combination, Middle Aged, Propranolol, Angina Pectoris
-
8
المؤلفون: A M, Sagirov, A Iu, Romakov, A B, Sumarokov, N A, Mazur
المصدر: Kardiologiia. 25(7)
مصطلحات موضوعية: Adult, Verapamil, Physical Exertion, Humans, Drug Synergism, Drug Therapy, Combination, Middle Aged, Propranolol, Angina Pectoris
-
9
المؤلفون: A Iu, Romakov, A M, Sagirov, V M, Desiatnichenko, Iu S, Sobol', A B, Sumarokov
المصدر: Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR. 6(2)
مصطلحات موضوعية: Adult, Male, Adrenergic beta-Antagonists, Hemodynamics, Middle Aged, Propranolol, Angina Pectoris, Propanolamines, Nadolol, Atenolol, Echocardiography, Exercise Test, Humans, Labetalol
-
10
المؤلفون: A Iu, Romakov, A M, Sagirov, A B, Sumarokov, N A, Mazur
المصدر: Klinicheskaia meditsina. 62(3)
مصطلحات موضوعية: Adult, Male, Time Factors, Dose-Response Relationship, Drug, Physical Exertion, Exercise Test, Hemodynamics, Drug Evaluation, Humans, Drug Therapy, Combination, Middle Aged, Propranolol, Angina Pectoris
-
11
المؤلفون: A B, Sumarokov, A Iu, Romakov, A M, Sagirov, V B, Iurkova, N A, Mazur
المصدر: Klinicheskaia meditsina. 62(3)
مصطلحات موضوعية: Adult, Male, Placebos, Time Factors, Dose-Response Relationship, Drug, Verapamil, Physical Exertion, Exercise Test, Humans, Coronary Disease, Middle Aged, Propranolol, Angina Pectoris
-
12
المؤلفون: A M, Sagirov, A Iu, Romakov, A B, Sumarokov, N A, Mazur
المصدر: Kardiologiia. 24(11)
مصطلحات موضوعية: Adult, Male, Dose-Response Relationship, Drug, Nifedipine, Verapamil, Heart Rate, Humans, Blood Pressure, Drug Therapy, Combination, Middle Aged, Angina Pectoris